ArticleCancer gene therapy2022

Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia.

Paniz Tavakoli Shirazi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.